Keith Pitts - Tenet Healthcare Vice Chairman
| THC Stock | USD 94.85 1.66 1.78% |
Chairman
Mr. Keith B. Pitts is no longer Vice Chairman of the Company, effective August 31, 2019. Mr. Pitts was appointed vice chairman following Tenets acquisition of Vanguard Health Systems, Inc. in October 2013. He was Vanguards vice chairman from May 2001 until the acquisition and an executive vice president from August 1999 until May 2001. Mr. Pitts also served as a director of Vanguard from August 1999 until September 2004. Before joining Vanguard, Mr. Pitts was the chairman and chief executive officer of Mariner PostAcute Network and its predecessor, Paragon Health Network, a nursing home management company, from November 1997 until June 1999. He served as the executive vice president and chief financial officer for OrNda HealthCorporation prior to its acquisition by Tenet, from August 1992 to January 1997, and, before that, as a consultant to many healthcare organizations, including as a partner in Ernst Youngs healthcare consulting practice since 2013.
| Age | 60 |
| Tenure | 11 years |
| Address | 14201 Dallas Parkway, Dallas, TX, United States, 75254 |
| Phone | 469 893 2200 |
| Web | https://www.tenethealth.com |
Tenet Healthcare Management Efficiency
The company has Return on Asset of 0.0629 % which means that on every $100 spent on assets, it made $0.0629 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2592 %, implying that it generated $0.2592 on every 100 dollars invested. Tenet Healthcare's management efficiency ratios could be used to measure how well Tenet Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.04. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Tenet Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 209.6 M, whereas Intangible Assets are forecasted to decline to about 1.4 B.Similar Executives
| Showing other executives | CHAIRMAN Age | ||
| Rocco Ortenzio | Select Medical Holdings | 91 | |
| Lee Wielansky | Brookdale Senior Living | 69 | |
| Stephen Everett | AMN Healthcare Services | 61 | |
| Bruce Shear | Acadia Healthcare | 62 | |
| Leo Higdon | Encompass Health Corp | 74 | |
| Mark Heaney | Addus HomeCare | 58 | |
| Douglas Wheat | AMN Healthcare Services | 70 | |
| Milton Johnson | HCA Holdings | 60 | |
| Edward Kuntz | US Physicalrapy | 76 | |
| Kent Thiry | DaVita HealthCare Partners | 63 | |
| Wayne DeVeydt | Surgery Partners | 54 | |
| Guy Sansone | Brookdale Senior Living | 55 | |
| Thomas Frist | HCA Holdings | 85 | |
| Jerald Pullins | US Physicalrapy | 76 | |
| Alan Miller | Universal Health Services | 86 | |
| Robert Ortenzio | Select Medical Holdings | 66 | |
| Roy Christensen | The Ensign Group | 84 | |
| Henry Esber | InnovAge Holding Corp | 78 | |
| Brad Sampson | AMN Healthcare Services | N/A | |
| Joey Jacobs | Acadia Healthcare | 63 | |
| Daniel Decker | Brookdale Senior Living | 63 | |
Management Performance
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.0629 |
Tenet Healthcare Leadership Team
Elected by the shareholders, the Tenet Healthcare's board of directors comprises two types of representatives: Tenet Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tenet. The board's role is to monitor Tenet Healthcare's management team and ensure that shareholders' interests are well served. Tenet Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tenet Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Johnston, Chief USPI | ||
| Richard Pettingill, Independent Director | ||
| Nadja West, Independent Director | ||
| Paola Arbour, Executive Vice President, Chief Information Officer | ||
| William III, Vice Relations | ||
| J Kerrey, Lead Independent Director | ||
| Robert Kerrey, Independent Director | ||
| Brenda Gaines, Independent Director | ||
| Sun Park, Executive CFO | ||
| Michael Maloney, Executive Development | ||
| John Byrnes, Independent Director | ||
| Edward Kangas, Independent Chairman of the Board | ||
| James Bierman, Independent Director | ||
| Thomas Arnst, Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary | ||
| Daniel Cancelmi, Chief Financial Officer, Executive Vice President | ||
| Audrey Andrews, Executive Vice President, General Counsel, Corporate Secretary | ||
| Ronald Rittenmeyer, Executive Chairman of the Board, Chief Executive Officer | ||
| Jana Durfee, Senior Officer | ||
| Brendan Strong, Chief Financial Officer | ||
| Ernest Franklin, Chief Medical Operations Officer | ||
| Meghan FitzGerald, Independent Director | ||
| Bill Durham, Chief Network | ||
| Tim Adams, Senior Vice President - Operations and Integration | ||
| Christopher Lynch, Independent Director | ||
| Cecil Haney, Independent Director | ||
| Liz Johnson, Chief Officer | ||
| Richard Fisher, Independent Director | ||
| Britt Reynolds, President of Hospital Operations | ||
| Howard Hacker, Executive Vice President, Chief Compliance Officer | ||
| Lloyd Austin, Independent Director | ||
| Trevor Fetter, Chairman, CEO and President and Member of Executive Committee | ||
| Richard Mark, Independent Director | ||
| Lisa Foo, Executive Vice President - Commercial Operations | ||
| Karen Garrison, Independent Director | ||
| Peter Wilver, Independent Director | ||
| Tammy Romo, Independent Director | ||
| James Unruh, Independent Director | ||
| Randolph Simpson, Independent Director | ||
| Freda LewisHall, Independent Director | ||
| Robert Webb, Chief Human Resource Officer, Senior Vice President | ||
| Matthew Ripperger, Independent Director | ||
| Saumya Sutaria, President, Chief Executive Officer, Chief Operating Officer, Director | ||
| Regina Nethery, Vice President of Investor Relations | ||
| Keith Pitts, Vice Chairman | ||
| Saumya MD, CEO and President | ||
| Sandra Karrmann, Chief Human Resource Officer, Executive Vice President | ||
| Marie Quintana, Executive Vice President - Communications, Chief Marketing Officer | ||
| Eric Evans, President - Hospital Operations | ||
| Clint Hailey, Chief VP |
Tenet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tenet Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.0629 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 28.2 B | ||||
| Shares Outstanding | 99.19 M | ||||
| Shares Owned By Insiders | 1.30 % | ||||
| Shares Owned By Institutions | 97.81 % | ||||
| Number Of Shares Shorted | 4.26 M | ||||
| Price To Earning | 11.95 X |
Currently Active Assets on Macroaxis
When determining whether Tenet Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenet Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenet Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenet Healthcare Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.Note that the Tenet Healthcare information on this page should be used as a complementary analysis to other Tenet Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Tenet Stock analysis
When running Tenet Healthcare's price analysis, check to measure Tenet Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenet Healthcare is operating at the current time. Most of Tenet Healthcare's value examination focuses on studying past and present price action to predict the probability of Tenet Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenet Healthcare's price. Additionally, you may evaluate how the addition of Tenet Healthcare to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Tenet Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenet Healthcare. If investors know Tenet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenet Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.403 | Earnings Share 5.71 | Revenue Per Share 202.166 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0629 |
The market value of Tenet Healthcare is measured differently than its book value, which is the value of Tenet that is recorded on the company's balance sheet. Investors also form their own opinion of Tenet Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tenet Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenet Healthcare's market value can be influenced by many factors that don't directly affect Tenet Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenet Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenet Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenet Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.